HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS: DIAGNOSIS, DETECTION OF CAUSES AND THERAPY EFFICIENCY

The lecture intended for general practitioners represents collated information on the most important mechanisms of brain damage under HIV infection, the rate of neurocognitive disorders and their role in disability of patients, classification of these disorders. The capabilities and importance of diagnosis and an in-depth work-up of patients for establishing complete clinical diagnosis and order of effective treatment are presented in the lecture. Much attention is given to immunosuppression influence, brain cell elements involvement and forming of reservoir of HIV infection in pathogenesis of neurocognitive diseases. The lecture describes special aspects of radiology examinations including magnetic resonance imaging, magnetic resonance spectroscopy for assessment of metabolism and tissue perfusion using some chemical markers. Approaches to prevention, diagnosis and treatment are provided taking into account the stage of a disease. An algorithm of detection of causes and diagnosis of cognitive disorders is stated in the lecture and the role of different diagnostic approaches at different stages of HIV infection including HIV-associated diseases is shown.

1. Grant I., Atkinson J.H., Hesselink J.R., Kennedy C.J., Richman D.D., Spector S.A., McCutchan J.A. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann. Intern. Med., 1987, Vol. 107, No. 6, pp. 828–836.

2. Antinori A., Arendt G., Becker J.T., Brew B.J., Byrd D.A., Cherner M., Clifford D.B., Cinque P., Epstein L.G., Goodkin K., Gisslen M., Grant I., Heaton R.K., Joseph J., Marder K., Marra C.M., McArthur J.C., Nunn M., Price R.W., Pulliam L., Robertson K.R., Sacktor N., Valcour V., Wojna V.E. Updated research nosology for HIV-associated neurocognitive disorders. J. Neurol., 2007, Vol. 69, No. 18, pp. 1789–1799.

3. Heaton R.K., Franklin D.R., Ellis R.J., McCutchan J.A., Letendre S.L., Leblanc S., Corkran S.H., Duarte N.A., Clifford D.B., Woods S.P., Collier A.C., Marra C.M., Morgello S., Mindt M.R., Taylor M.J., Marcotte T.D., Atkinson J.H., Wolfson T., Gelman B.B., McArthur J.C., Simpson D.M., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I.; CHARTER Group; HNRC Group. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol., 2011, Vol. 17, No. 1, pp. 3–16.

4. Ellis R.J., Badiee J., Vaida F., Letendre S., Heaton R.K., Clifford D., Collier A.C., Gelman B., McArthur J., Morgello S., McCutchan J.A., Grant I; CHARTER Group. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS, 2011, Vol. 25, No. 14, pp. 1747–1751.

5. Weber E., Morgan E.E., Iudicello J.E., Blackstone K., Grant I., Ellis R.J., Letendre S.L., Little S., Morris S., Smith D.M., Moore D.J., Woods S.P.; TMARC Group. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J. Neurovirol., 2013, Vol. 19, No. 1, pp. 65–74. URL: DOI: 10.1007/s13365-012-0141-y (Epub. 2012, Dec. 19).

6. Cherner M., Letendre S., Heaton R.K., Durelle J., Marquie-Beck J., Gragg B., Grant I. HIV Neurobehavioral Research Center Group. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. J. Neurol., 2005, Vol. 64, No. 8, pp. 1343–1347.

7. Purohit V., Rapaka R., Shurtleff D. Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. Mol. Neurobiol., 2011, Vol. 44, pp. 102–110.

8. Doyle K.L., Morgan E.E., Morris S., Smith D.M., Little S., Iudicello J.E., Blackstone K., MooreIgor D.J., Letendre S.L., Paul S. Cite as Realworld impact of neurocognitive deficits in acute and early HIV infection, Journal of NeuroVirology, 2013, Vol. 19, Issue 6, pp. 565–573.

9. Valcour V., Shikuma C., Shiramizu B., Watters M., Poff P., Selnes O., Holck P., Grove J., Sacktor N. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. J. Neurol., 2004, Vol. 63, No. 5, pp. 822–827.

10. Woods S.P., Dawson M.S., Weber E. The semantic relatedness of cue-intention pairings influences event-based prospective memory failures in older adults with HIV infection. J. Clin. Exp. Neuropsychol., 2010, Vol. 32, No. 4, pp. 398–407.

11. Doyle K., Weber E., Atkinson J.H., Grant I., Woods S.P.; HIV Neurobehavioral Research Program (HNRP) Group. Aging, prospective memory, and health-related quality of life in HIV infection. AIDS Behav., 2012, Vol. 16, No. 8, pp. 2309–2318.

12. Morgan E.E., Woods S.P., Smith C., Weber E., Scott J.C., Grant I.; HIV Neurobehavioral Research Program (HNRP) Group. Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND). AIDS Behav., 2012, Vol. 16, No. 8, pp. 2279–2285.

13. Беляков Н.А., Медведев С.В., Трофимова Т.Н. Механизмы поражения головного мозга при ВИЧ-инфекции // Вестник Российской академии наук. 2012. № 9. С. 4–12. [Belyakov N.A., Medvedev S.V., Trofimova T.N. Mechanisms of brain damage in HIV infection. Herald of the Russian Academy of Sciences, 2012, No. 9, pp. 4–12 (In Russ.)].

14. Незнанов Н.Г., Халезова Н.Б. Особенности совладающего поведения у ВИЧ-инфицированных больных // Экология человека. 2010. № 4. С. 10–15. [Neznanov N.G., Khalezova N.B. Features of coping behavior in HIV-infected patients. Human Ecology, 2010, No. 4, pp. 10–15 (In Russ.)].

15. Громова Е.А., Богдан А.А., Катаева Г.В., Котомин И.А., Хоменко Ю.Г., Коротков А.Д., Трофимова Т.Н., Рассохин В.В., Беляков Н.А. Особенности функционального состояния структур головного мозга у ВИЧ-инфицированных пациентов // Лучевая диагностика и терапия. 2016. № 1 (7). С. 41–48. [Gromova E.A., Bogdan A.A., Kataeva G.V., Kotomin I.A., Khomenko Yu.G., Korotkov A.D., Trofimova T.N., Rassokhin V.V., Belyakov N.A. Features of the functional state of brain structures in HIV-infected patients. Radiology Diagnostics and Therapy, 2016, Vol. 1, No. 7, pp. 41–48 (In Russ.)].

16. Гайсина А.В., Магонов Е.П., Громова Е.А., Гурская О.Е., Трофимова Т.Н., Рассохин В.В., Беляков Н.А. Патологические механизмы ВИЧассоциированных нейрокогнитивных расстройств // Лучевая диагностика и терапия. 2016. № 2 (7). С. 6–21. [Gaysina A.V., Magonov E.P., Gromova E.A., Gurskaya O.E., Trofimova T.N., Rassokhin V.V., Belyakov N.A. Pathological mechanisms of HIV-associated neurocognitive disorders // Radialogy Diagnostics and Therapy, 2016, Vol. 2, No. 7, pp. 6–21 (In Russ.)].

17. Трофимова Т.Н., Бакулина Е.Г., Рассохин В.В., Беляков Н.А. Поражения головного мозга у ВИЧ-инфицированных пациентов. Клиниколабораторные и радиологические сопоставления // Медицинский академический журнал. 2015. Т. 15, № 4. С. 31–38. [Trofimova T.N., Bakulina E.G., Rassokhin V.V., Belyakov N.A. Brain lesions in HIV-infected patients. Clinical, laboratory and radiological comparisons. Medical Academic Journal, 2015, Vol. 15, No. 4, pp. 31–38 (In Russ.)].

18. Халезова Н.Б., Незнанов Н.Г., Беляков Н.А. ВИЧ-инфекция и психические расстройства: современный взгляд на проблему // Медицинский академический журнал. 2014. Т. 14, № 3. С. 14–32. [Halezova N.B., Neznanov N.G., Belyakov N.A. HIV infection and mental disorders: a contemporary perspective on the problem. Medical Academic Journal, 2014, Vol. 14, No. 3, pp. 14–32 (In Russ.)].

19. Беляков Н.А., Рассохин В.В., Трофимова Т.Н. Диагностика и механизмы поражения центральной нервной системы // Медицинский академический журнал. 2012. Т. 12, № 2. С. 56–67. [Belyakov N.A., Rassokhin V.V., Trofimova T.N. Diagnosis and mechanisms of Central nervous system damage. Medical Academic Journal, 2012, Vol. 12, No. 2, pp. 56–67 (In Russ.)].

20. Гайсина А.В., Рассохин В.В., Дементьева Н.Е., Беляков Н.А. Патофизиология ВИЧ-ассоциированных нейрокогнитивных расстройств // ВИЧ-инфекция и иммуносупрессии. 2014. Т. 6, № 2. С. 25–40. [Gaysina A.V., Rassokhin V.V., Dement’eva N.Ye., Belyakov N.A. Pathophysiology of HIV-associated neurocognitive disorders. HIV Infection and Immunosuppressive Disorders, 2014, Vol. 6, No. 2, pp. 25–40 (In Russ.)].

21. Громова Е.А., Богдан А.А., Котомин И.А., Катаева Г.В., Трофимова Т.Н., Рассохин В.В., Беляков Н.А. Метаболические характеристики нейрокогнитивных расстройств у ВИЧ-инфицированных пациентов // ВИЧ-инфекция и иммуносупрессии. 2014. Т. 6, № 4. С. 104–106. [Gromova E.A., Bogdan A.A., Kotomin I.A., Kataeva G.V., Trofimova T.N., Rassokhin V.V., Belyakov N.A. Metabolic characteristics of neurocognitive disorders in HIV-infected patients. HIV Infection and Immunosuppressive Disorders, 2014, Vol. 6, No. 4, pp. 104–106 (In Russ.)].

22. Рассохин В.В., Сизова Т.Д., Дементьева Н.Е., Громова Е.А., Трофимова Т.Н., Гурская О.Е., Беляков Н.А. Выбор методов нейропсихологической, клинической и инструментальной диагностики ВИЧ-обусловленных нейрокогнитивных расстройств // ВИЧ-инфекция и иммуносупрессии. 2013. Т. 5, № 1. С. 42–53. [Rassokhin V.V., Sizova T.D., Dement’eva N.Ye., Gromova E.A., Trofimova T.N., Gurskaya O.E., Belyakov N.A. The choice of methods of neuropsychological, clinical and instrumental diagnosis of HIV-induced neurocognitive disorders. HIV Infection and Immunosuppressive Disorders, 2013, Vol. 5, No. 1, pp. 42–53 (In Russ.)].

23. Дементьева Н.Е., Сизова Н.В., Лисицина З.Н., Беляков Н.А. Молекулярно-эпидемиологическая характеристика ВИЧ-инфекции в СанктПетербурге // Медицинский академический журнал. 2012. Т. 12, № 2. С. 97–104. [Dement’eva N.Ye., Sizova N.V., Lisitsyna Z.N., Belyakov N.A. Molecular epidemiological characteristics of HIV infection in Saint-Petersburg. Medical Academic Journal, 2012, Vol. 12, No. 2, pp. 97–104 (In Russ.)].

24. Гурская О.Е., Галичева Е.В., Гайсина А.В., Рассохин В.В., Сизова Т.Д., Беляков Н.А., Медведев С.В. Электрофизиологические методы в диагностике субклинических когнитивных нарушений у ВИЧ-инфицированных больных // Журнал инфектологии. 2012. Т. 4, № 3. С. 80–87. [Gurskaya O.E., Galicheva E.V., Gaysina A.V., Rassokhin V.V., Sizova T.D., Belyakov N.A., Medvedev S.V. Electrophysiological methods in the diagnosis of subclinical cognitive impairment in HIV-infected patients. Journal of Infectology, 2012, Vol. 4, No. 3, pp. 80–87 (In Russ.)].

25. Трофимова Т.Н., Беляков Н.А. Многоликая нейрорадиология ВИЧ-инфекции // Лучевая диагностика и терапия. 2010. № 3 (1). С. 3–11. [Trofimova T.N., Belyakov N.A. Multifaceted Neuroradiology of HIV infection. Radiolody Diagnostics and Therapy, 2010, Vol. 3, No. 1, pp. 3–11 (In Russ.)].

26. Беляков Н.А., Рассохин В.В., Сизова Т.Д., Гайсина А.В., Кольцова О.В., Пархоменко С.И., Громова E.А. Особенности проявлений нейрокогнитивных расстройств у больных при ВИЧ-инфекции // ВИЧ-инфекция и иммуносупрессии. 2013. Т. 5, № 1. С. 76–86. [Belyakov N.A., Rassokhin V.V., Sizova T.D., Gaysina A. V., Koltsova O.V., Parkhomenko S.I., Gromova E.A. Features of manifestations of neurocognitive disorders in patients with HIV infection. HIV Infection and Immunosuppressive Disorders, 2013, Vol. 5, No. 1, pp. 76–86 (In Russ.)].

27. Беляков Н.А., Рассохин В.В., Трофимова Т.Н. Совет экспертов по проблеме ВИЧ-ассоциированных нейрокогнитивных расстройств (29 ноября 2013 года, Москва // ВИЧ-инфекция и иммуносупрессии, 2014, Т. 6, № 1. С. 106–109. [Belyakov N.A., Rassokhin V.V., Trofimova T.N. The Board of experts for HIV-associated neurocognitive disorders (29 November 2013, Moscow. HIV Infection and Immunosuppressivisorders, 2014, Vol. 6, No. 1, pp. 106–109 (In Russ.)].

28. Blackstone K., Moore D.J., Heaton R.K., Franklin D.R. Jr., Woods S.P., Clifford D.B., Collier A.C., Marra C.M., Gelman B.B., McArthur J.C., Morgello S., Simpson D.M., Rivera-Mindt M., Deutsch R., Ellis R.J., Hampton Atkinson J., Grant I. CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. Int. Neuropsychol. Soc., 2012, Vol. 18, No. 1, pp. 79–88.

29. Focà E., Magro P., Motta D., Compostella S., Casari S., Bonito A., Brianese N., Ferraresi A., Rodari P., Pezzoli M.C., Quiros-Roldan E., Castelli F. Screening for neurocognitive impairment in HIV-infected individuals at first contact after HIV diagnosis: the experience of a large clinical center in Northern Italy. Int. J. Mol. Sci., 2016, Vol. 17, pp. 434.

30. Woods S.P., Weber E., Weisz B.M., Twamley E.W., Grant I.; HIV Neurobehavioral Research Programs Group. Prospective memory deficits are associated with unemployment in persons living with HIV infection. Rehabil. Psychol., 2011, Vol. 56, No. 1, pp. 77–84.

31. Heaton R.K., Marcotte T.D., Mindt M.R., Sadek J., Moore D.J., Bentley H., McCutchan J.A., Reicks C., Grant I.; HNRC Group. The impact of HIV-associated neuropsychological impairment on everyday functioning. Int. Neuropsychol. Soc., 2004, Vol. 10, No. 3, pp. 317–331.

32. Wilkie F.L., Goodkin K., Eisdorfer C., Feaster D., Morgan R., Fletcher M.A., Blaney N., Baum M., Szapocznik J. Mild cognitive impairment and risk of mortality in HIV-1 infection. J. Neuropsychiatry Clin. Neurosci., 1998, Vol. 10, No. 2, pp. 125–132.

33. Hinkin C.H., Castellon S.A., Durvasula R.S. et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. J. Neurol., 2002, Vol. 59, No. 12, pp. 1944–1950.

34. Letendre S., Marquie-Beck J., Capparelli E., Best B., Clifford D., Collier A.C., Gelman B.B., McArthur J.C., McCutchan J.A., Morgello S., Simpson D., Grant I., Ellis R.J.; CHARTER Group. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch. Neurol., 2008, Vol. 65, No. 1, pp. 65–70.

35. Reger M., Welsh R., Razani J., Martin D.J., Boone K.B. A meta-analysis of the neuropsychological sequelae of HIV infection. J. Int. Neuropsychol. Soc., 2002, Vol. 8, No. 3, pp. 410–424.

36. Martin E.M., Pitrak D.L. Weddington W., Rains N.A., Nunnally G., Nixon H., Grbesic S., Vassileva J., Bechara A. Cognitive impulsivity and HIV serostatus in substance dependent males. Int. Neuropsychol. Soc., 2004, Vol. 10, No. 7, pp. 931–938.

37. Iudicello J.E., Woods S.P., Cattie J.E., Doyle K., Grant I. HIV Neurobehavioral Research Program Group. Risky decision-making in HIV-associated neurocognitive disorders (HAND). Clin. Neuropsychol., 2013, Vol. 27, No. 2, pp. 256–275.

38. Незнанов Н.Г., Халезова Н.Б., Хобейш М.А., Захарова Н.Г., Киссин М.Я., Беляков Н.А. Нейрофизиологические аспекты когнитивных нарушений у больных с ВИЧ-инфекцией // Журнал инфектологии. 2018. Т. 10, № 4. С. ... [Neznanov N.G., Khalezova N.B., Khobeysh M.A., Zakharova N.G., Kissin M.Ya., Belyakov N.A. Neurophysiological aspects of cognitive impairment in patients with HIV-infection Journal of Infectology, 2018, Vol. 10, No. 4, pp. ... (In Russ.)].

39. Woods S.P., Conover E., Rippeth J.D., Carey C.L., Gonzalez R., Marcotte T.D., Heaton R.K., Grant I.; HIV Neurobehavioral Research Center (HNRC) Group. Qualitative aspects of verbal fluency in HIV-associated dementia: a deficit in rule-guided lexical-semantic search processes? Neuropsychologia, 2004, Vol. 42, No. 6, pp. 801–809.

40. Woods S.P., Scott J.C., Dawson M.S., Morgan E.E., Carey C.L., Heaton R.K., Grant I.; HIV Neurobehavioral Research Center (HNRC) Group. Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an HIV-1 sample. Arch. Clin. Neuropsychol., 2005, Vol. 20, No. 8, pp. 1061–1071.

41. Iudicello J.E., Woods S.P., Weber E., Dawson M.S., Scott J.C., Carey C.L., Grant I.; HIV Neurobehavioral Research Center (HNRC) Group. Cognitive mechanisms of switching in HIV-associated category fluency deficits. J. Clin. Exp. Neuropsychol., 2008, Vol. 30, No. 7, pp. 797–804.

42. Mateen F.J., Shinohara R.T., Carone M., Miller E.N., McArthur J.C., Jacobson L.P., Sacktor N. Multicenter AIDS Cohort Study (MACS) Investigators. Neurologic disorders incidence in HIV+ vs HIV- men: Multicenter AIDS Cohort Study, 1996–2011. J. Neurol., 2012, Vol. 79, No. 18, pp. 1873–1880.

43. Kolson D. Neurologic complications in persons with HIV infection in the era of antiretrovirial thetapy. Top Antivir. Med., 2017, Vol. 25, No. 3, pp. 97–101.

44. Eggers C., Arendt G., Hahn K., Husstedt I.W., Maschke M., Neuen-Jacob E., Obermann M., Rosenkranz T., Schielke E., Straube E.; For the German Association of Neuro-AIDS und Neuro-Infectiology (DGNANI). HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J. Neurol., 2017, Vol. 264, No. 8, pp. 1715–1727.

45. Sacktor N., Skolasky R.L., Moxley R., Wang S., Mielke M.M., Munro C., Steiner J., Nath A., Haughey A.N., McArthur J. Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial. J. Neurovirol., 2018, Vol. 24, Issue 1, pp. 16–27.

46. Woods S.P., Moore D.J., Weber E., Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol. Rev., 2009, Vol. 19, No. 2, pp. 152–168.

47. Pascal S., Resnick L., Barker W.W., Loewenstein D., Yoshii F., Chang J.Y., Boothe T., Sheldon J., Duara R. Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings. J. Nucl. Med., 1991, Vol. 32, pp. 1725–1729.

48. Hinkin C.H., van Gorp W.G., Mandelkern M.A., Gee M., Satz P., Holston S., Marcotte T.D., Evans G., Paz D.H., Ropchan J.R. Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography. J. Neuropsychiatry Clin. Neurosci., 1995, Vol. 7, pp. 180–187.

49. von Giesen H.J., Antke C., Hefter H., Wenserski F., Seitz R.J., Arendt G. Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings. Arch. Neurol., 2000, Vol. 57, pp. 1601–1607.

50. Rottenberg D.A., Sidtis J.J., Strother S.C., Schaper K.A., Anderson J.R., Nelson M.J., Price R.W. Abnormal cerebral glucose metabolism in HIV1 seropositive subjects with and without dementia. J. Nucl. Med., 1996, Vol. 37, pp. 1133–1141.

51. Andersen A.B., Law I., Ostrowski S.R., Lebech A.M., Hoyer-Hansen G., Hojgaard L., Gerstoft J., Ullum H., Kjaer A. Self-reported fatigue common among optimally treated HIV patients: no correlation with cerebral FDG-PET scanning abnormalities. Neuroimmunomodulation, 2006, Vol. 13, pp. 69–75.

52. Towgood K.J., Pitkanen M., Kulasegaram R., Fradera A., Soni S., Sibtain N., Reed L.J., Bradbeer C., Barker G.J., Dunn J.T. Regional cerebral blood flow and FDG uptake in asymptomatic HIV-1 men. Hum. Brain Mapp., 2013, Vol. 34, pp. 2484–2493.

53. Bladowska J., Zimny A., Kołtowska A. et al. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation. Eur. J. Radiol., 2013, Vol. 82, No. 4, pp. 686–692.

54. Georgiou M.F., Gonenc A., Waldrop-Valverde D., Kuker R.A., Ezuddin S.H., Sfakianakis G.N., Kumar M. Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism. Nucl. Med., 2008, Vol. 49, pp. 1999–2005.

55. Hammoud D.A., Endres C.J., Chander A.R., Guilarte T.R., Wong D.F., Sacktor N.C., McArthur J.C., Pomper M.G. Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS. J. Neurovirol., 2005, Vol. 11, pp. 346–355.

56. Wiley C.A., Lopresti B.J., Becker J.T., Boada F., Lopez O.L., Mellors J., Meltzer C.C., Wisniewski S.R., Mathis C.A. Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment. J. Neurovirol., 2006, Vol. 12, pp. 262–271.

57. Garvey L.J., Pavese N., Ramlackhansingh A., Thomson E., Allsop J.M., Politis M., Kulasegaram R., Main J., Brooks D.J., Taylor-Robinson S.D. Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation. PLoS One, 2012, Vol. 7, pp. e38 980.

58. Garvey L.J., Pavese N., Politis M., Ramlackhansingh A., Brooks D.J., Taylor-Robinson S.D., Winston A. Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS, 2014, Vol. 28, pp. 67–72.

59. Chen N.C., Partridge A.T., Sell C., Torres C., Martín-García J. Fate of Microglia during HIV-1 Infection: From Activation to Senescence? Glia, 2017, Vol. 65, No. 3, pp. 431–446.

60. Wang G.J., Chang L., Volkow N.D., Telang F., Logan J., Ernst T., Fowler J.S. Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain, 2004, Vol. 127, pp. 2452–2458.

61. Chang L., Wang G.J., Volkow N.D., Ernst T., Telang F., Logan J., Fowler J.S. Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage, 2008, Vol. 42, pp. 869–878.

62. Nishijima T., Gatanaga H., Teruya K., Tajima T., Kikuchi Y., Hasuo K., Oka S. Brain magnetic resonance imaging screening is not useful for HIV1-infected patients without neurological symptoms. AIDS Res. Hum. Retroviruses, 2014, Vol. 30, No. 10, pp. 970–974.

63. Peluso M.J., Meyerhoff D.J., Price R.W., Peterson J., Lee E., Young A.C., Walter R., Fuchs D., Brew B.J., Cinque P., Robertson K., Hagberg L., Zetterberg H., Gisslén M., Spudich S. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. J. Infect. Dis., 2013, Vol. 207, No. 11, pp. 1703–1712.

64. Mohamed M.A., Barker P.B., Skolasky R.L., Selnes O.A., Moxley R.T., Pomper M.G., Sacktor N.C. Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn. Reson. Imaging, 2010, Vol. 28, No. 9, pp. 1251–1257.

65. Vigneswaran S., Rojas J.H., Garvey L., Taylor-Robinson S., Winston A. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts. Neuroradiol. J., 2015, Vol. 28, No. 6, pp. 545–554.